A spokesman for EU regulators said the European Drug Administration is expected to approve the COVID-19 vaccine against O'Micron mutant developed by Pfizer Inc-BioNTech this autumn, Agence France-Presse reported. In June, Pfizer Inc and BioNTech SE of Germany said that both COVID-19 vaccines developed for O'Micron had triggered a "high immune response". One is a fortified vaccine for O'Micron, and the other is a bivalent vaccine for the original virus and O'Micron.
欧盟有望在今秋批准辉瑞-BioNTech针对奥密克戎开发的新冠疫苗
The European Union is expected to approve the COVID-19 vaccine developed by Pfizer Inc-BioNTech against O'Micron this autumn.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.